Blog
TFX vs. PEN: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks is more attractive to value investors? We'll need to
STRW or OHI: Which Is the Better Value Stock Right Now?
Investors interested in REIT and Equity Trust - Other stocks are likely familiar with Strawberry Fields REIT, Inc. (STRW) and Omega Healthcare Investors (OHI). But which of these two stocks is more
LXFR vs. SXI: Which Stock Is the Better Value Option?
Investors with an interest in Manufacturing - General Industrial stocks have likely encountered both Luxfer (LXFR) and Standex International (SXI). But which of these two companies is the best
JMPLY or APD: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Chemical - Diversified sector have probably already heard of Johnson Matthey PLC (JMPLY) and Air Products and Chemicals (APD). But which of these two
VIRT vs. BAM: Which Stock Should Value Investors Buy Now?
Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Virtu Financial (VIRT) and Brookfield Asset Management (BAM). But which of these two stocks presents
JSAIY vs. WMT: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Retail - Supermarkets sector have probably already heard of J. Sainsbury PLC (JSAIY) and Walmart (WMT). But which of these two companies is the best option
MARUY or HON: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Diversified Operations sector might want to consider either Marubeni Corp. (MARUY) or Honeywell International Inc. (HON). But which of these two stocks presents
TAL vs. LINC: Which Stock Is the Better Value Option?
Investors with an interest in Schools stocks have likely encountered both TAL Education (TAL) and Lincoln Educational Services Corporation (LINC). But which of these two stocks presents investors
3 S&P 500 Bank Stocks With More Than 4% Dividend Yield to Watch
With the Federal Reserve reducing interest rates and economic growth showing resilience, the outlook for the banking sector is turning more favorable. Lower borrowing costs will likely stimulate
Will Rising User Base Continue to Drive Axon's Software & Services Unit?
Axon Enterprise, Inc. AXON is benefiting from strong momentum in the Software & Services segment. An increase in the aggregate number of users to the Axon network is supporting the segment’s
Here's Why Investors Should Consider Selling NOV Stock Now
NOV Inc. NOV has grown into a global leader in oilfield equipment and technology with operations spanning 548 locations across six continents. NOV delivers integrated systems, drilling equipment and
Cintas' Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Cintas Corporation CTAS reported first-quarter fiscal 2026 (ended Aug. 31, 2025) earnings of $1.20 per share, which beat the Zacks Consensus Estimate of $1.19. The bottom line rose 9.1% year over
COMM Rides on Strong Customer Growth: Will it Fuel Revenue Growth?
CommScope Holding Company, Inc. COMM is witnessing strong customer growth across multiple segments. The company’s strong emphasis on research and innovation, and portfolio expansion, aligned with
Wolfspeed (WOLF) Up 51.1% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Wolfspeed (WOLF). Shares have added about 51.1% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue
Why Is Semtech (SMTC) Up 4.4% Since Last Earnings Report?
A month has gone by since the last earnings report for Semtech (SMTC). Shares have added about 4.4% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent
Heico (HEI) Down 3.7% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Heico Corporation (HEI). Shares have lost about 3.7% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue
MKTX Unveils Axess IQ Connect to Modernize Fixed-Income Trading
MarketAxess Holdings Inc. MKTX has launched Axess IQ Connect, a new mobile-friendly solution designed especially for private banks and wealth managers. This lightweight web-based application is
FIS Revamps Private Capital Suite to Transform Private Equity Operations
A global financial technology provider, Fidelity National Information Services, Inc. FIS, recently launched an upgraded version of its Private Capital Suite, transforming it into a cloud-native
BigBear.ai & SMX Strengthen Naval Operations With AI at UNITAS 2025
BigBear.ai Holdings, Inc. BBAI, a global leader in AI-powered decision solutions for defense and national security, has reinforced its collaboration with the U.S. government. The company will deploy
Insider Buys: 3 Small-Cap Stocks CEOs are Buying
Small-caps have been a strong trade over recent weeks, with the rate cut outlook providing strong tailwinds. Cheaper capital is a huge benefit for these smaller companies, explaining the rally.
And
Micron Beats on Q4 Earnings: Will Strong Guidance Lift the Stock?
Micron Technology (MU) reported fourth-quarter fiscal 2025 earnings of $3.03 per share, beating the Zacks Consensus Estimate by 5.9%. The company’s fourth-quarter earnings jumped 156.8% year over
Must-Watch Robotics Stocks That Could Drive Future Growth Trends
An updated edition of the August 4, 2025, article.The second half of 2025 has witnessed an unprecedented surge in robotics adoption across industries worldwide, driven by breakthrough AI integration
Pre-Markets Return to Positive Territory
Yesterday, market participants took a powder from the latest leg of the bull rally, finishing in the red across major indexes: the Dow -0.19%, S&P 500 -0.55% and Nasdaq -0.95% as of the closing
REPL Stock Plunges 54% in 3 Months After FDA Rejects Skin Cancer Drug
Replimune Group’s REPL share price tumbled 54.2% over the past three months. The massive setback was observed after the FDA issued a complete response letter (CRL) in July, against the biologics



